Research in this emphasis addresses pathomechanisms of cardiovascular diseases, including myocardial dysfunction and infarction, atherosclerosis, arteritis, thrombosis and embolism as well as kidney dysfunction. It also covers investigations on the development of the cardiovascular system and the evaluation of therapeutic concepts.
Probes & Targets
The design, chemical synthesis and characterization of imaging probes and theranostic agents as well as reporter genes used to study cardiovascular diseases including, myocardial pathologies, vascular diseases and diseases of the kidney will be addressed. All imaging modalities will be covered.
All applications in cardiovascular research where new imaging tools, probes and therapeutics are evaluated on cells or animals belong to this category. It also includes the preclinical testing of image-guided therapies.
In this category, cardiovascular research will be presented that mainly addresses new biological mechanisms and where imaging is rather used as a tool to gain the mechanistic insights. New approaches in bioengineering and new disease models will be considered.
Translational and Human Studies
Cardiovascular research on humans or (non-human) studies with demonstrated potential for clinical impact or immediate translation should be submitted to this category. It includes prospective and retrospective studies as well as studies on new pharmaceuticals at phase I-IV where imaging plays a significant role in the study. Studies on Omics and its combination with imaging are also welcome.